206 related articles for article (PubMed ID: 38010458)
1. Benefits and Harms of Mammography Screening in 75 + Women to Inform Shared Decision-making: a Simulation Modeling Study.
Jayasekera J; Stein S; Wilson OWA; Wojcik KM; Kamil D; Røssell EL; Abraham LA; O'Meara ES; Schoenborn NL; Schechter CB; Mandelblatt JS; Schonberg MA; Stout NK
J Gen Intern Med; 2024 Feb; 39(3):428-439. PubMed ID: 38010458
[TBL] [Abstract][Full Text] [Related]
2. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
3. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
4. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
[TBL] [Abstract][Full Text] [Related]
5. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
Schousboe JT; Kerlikowske K; Loh A; Cummings SR
Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
[TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.
Nelson HD; O'Meara ES; Kerlikowske K; Balch S; Miglioretti D
Ann Intern Med; 2016 Feb; 164(4):226-35. PubMed ID: 26756902
[TBL] [Abstract][Full Text] [Related]
7. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
[TBL] [Abstract][Full Text] [Related]
8. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
[TBL] [Abstract][Full Text] [Related]
9. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography.
Stout NK; Lee SJ; Schechter CB; Kerlikowske K; Alagoz O; Berry D; Buist DS; Cevik M; Chisholm G; de Koning HJ; Huang H; Hubbard RA; Miglioretti DL; Munsell MF; Trentham-Dietz A; van Ravesteyn NT; Tosteson AN; Mandelblatt JS
J Natl Cancer Inst; 2014 Jun; 106(6):dju092. PubMed ID: 24872543
[TBL] [Abstract][Full Text] [Related]
10. Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women.
van Ravesteyn NT; Schechter CB; Hampton JM; Alagoz O; van den Broek JJ; Kerlikowske K; Mandelblatt JS; Miglioretti DL; Sprague BL; Stout NK; de Koning HJ; Trentham-Dietz A; Tosteson ANA;
J Natl Cancer Inst; 2021 Aug; 113(8):1017-1026. PubMed ID: 33515225
[TBL] [Abstract][Full Text] [Related]
11. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
[TBL] [Abstract][Full Text] [Related]
12. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Siu AL;
Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
[TBL] [Abstract][Full Text] [Related]
13. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.
Sprague BL; Stout NK; Schechter C; van Ravesteyn NT; Cevik M; Alagoz O; Lee CI; van den Broek JJ; Miglioretti DL; Mandelblatt JS; de Koning HJ; Kerlikowske K; Lehman CD; Tosteson AN
Ann Intern Med; 2015 Feb; 162(3):157-66. PubMed ID: 25486550
[TBL] [Abstract][Full Text] [Related]
14. Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
van den Broek JJ; Schechter CB; van Ravesteyn NT; Janssens ACJW; Wolfson MC; Trentham-Dietz A; Simard J; Easton DF; Mandelblatt JS; Kraft P; de Koning HJ
J Natl Cancer Inst; 2021 Apr; 113(4):434-442. PubMed ID: 32853342
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
[TBL] [Abstract][Full Text] [Related]
16. Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling.
Chapman CH; Schechter CB; Cadham CJ; Trentham-Dietz A; Gangnon RE; Jagsi R; Mandelblatt JS
Ann Intern Med; 2021 Dec; 174(12):1637-1646. PubMed ID: 34662151
[TBL] [Abstract][Full Text] [Related]
17. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
[TBL] [Abstract][Full Text] [Related]
18. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Nelson HD; Pappas M; Cantor A; Griffin J; Daeges M; Humphrey L
Ann Intern Med; 2016 Feb; 164(4):256-67. PubMed ID: 26756737
[TBL] [Abstract][Full Text] [Related]
19. Screening mammography in older women: a review.
Walter LC; Schonberg MA
JAMA; 2014 Apr; 311(13):1336-47. PubMed ID: 24691609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
